Selectively targeting myeloid-derived suppressor cells through TRAIL receptor 2 to enhance the efficacy of CAR T cell therapy for treatment of breast cancer
暂无分享，去创建一个
S. Gottschalk | A. Leen | V. Hoyos | N. Watanabe | P. Bajgain | Saisha A Nalawade | Robin Parihar | M. McKenna | Arushana Ali | L. Kelly | Paul Shafer | Mary K. McKenna | Jarrett Joubert | Juan Fernando Vera Valdes | P. Shafer